In a new study of more than 36,000 breast cancer cases over 24 years, researchers reaffirm that regular mammography significantly reduces the risk of dying from breast cancer.
In the study, presented at the Radiological Society of North America (RSNA) Annual Conference in Chicago, researchers examined mammography in 36,079 Swedish women diagnosed with breast cancer between 1992 and 2016. We investigated the status of participation in testing. The study authors noted that 4,564 of the women participated in breast cancer screening. Research shows that she died of breast cancer.
Researchers found that breast cancer survival rates ranged from 82.7 percent to 86.9 percent for women who participated in the last five mammograms before breast cancer diagnosis. In contrast, women who did not undergo these screenings before diagnosis had a survival rate of 59.1 to 77.6 percent, according to the study authors.
Researchers highlighted that adherence to five mammograms before diagnosis reduced the risk of death from breast cancer by 72 percent compared to women who did not undergo mammography.
“Women who had all five previous mammograms before being diagnosed with breast cancer were nearly three times less likely to die from breast cancer than women who had no mammograms at all; “Every time you get tested, you get an additional benefit in preventing death from breast cancer,” said study co-author Robert A. Smith, senior vice president and director of cancer screening at the American Cancer Society in Atlanta. said the doctor.
Although 73 to 96 percent of study participants had at least one of five scheduled mammography exams before diagnosis, researchers noted the common nature of mammography exams being irregular. According to Smith and colleagues, only 58% to 73% of women in the study attended their five scheduled mammograms before diagnosis.
“If a woman does not know she has breast cancer and misses or postpones a mammogram at a time when her breast cancer is growing and possibly metastasizing, even though she has no symptoms, the opportunity for early detection is lost. ”, Dr. Smith argued.
(Editor’s note: Click here for more information about the RSNA 2023 Annual Conference.)